ArticleJournal of Korean medical science2025
Analysis of National Sample Cohort From Korea for Epidemiological and Prognostic Aspects of Parkinson's Disease According to Time of Onset.
Article in Journal of Korean medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundParkinson's disease (PD) affects adults of all ages, with prognostic aspects varying based on the age of onset. This study compared the prognostic aspects of early-onset PD (EOPD) and late-onset PD (LOPD) in South Korea.
methodsWe analyzed PD patients aged ≥ 20 years registered at the National Sample Cohort between 2002 and 2019. PD patients were categorized into EOPD and LOPD. Five randomly selected individuals without PD were included as controls. Epidemiological data were analyzed for the two groups. Medical and socioeconomic variables, including body mass index (BMI), Charlson Comorbidity Index (CCI), smoking, and household income, were compared to controls to identify prognostic factors.
resultsPD incidence and prevalence per 100,000 significantly increased from 11.36 and 29.15 in 2003 to 26.10 and 174.52 in 2018, respectively. The proportion of EOPD among the PD patients decreased from 8.81% to 4.42%. LOPD patients had higher CCI scores than EOPD patients, and there were no significant changes in either group after 3 years from the index date. BMI significantly decreased in both LOPD and its control group 3 years after the index date. After the index date, smoking rate significantly decreased in LOPD and controls groups, but not in EOPD. EOPD patients exhibited significant differences in household income after 3 years from the index date.
conclusionPD incidence and prevalence gradually increased from 2003 to 2018, while the proportion of EOPD patients gradually decreased from a high value of 8.81%. For 3 years after PD diagnosis, EOPD and LOPD patients exhibited different comorbidities, smoking rate, and BMI patterns. EOPD patients were more vulnerable to negative economic outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.